216 related articles for article (PubMed ID: 14714440)
21. Empirically derived live-attenuated vaccines against dengue and Japanese encephalitis.
Saluzzo JF
Adv Virus Res; 2003; 61():419-43. PubMed ID: 14714439
[No Abstract] [Full Text] [Related]
22. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
[TBL] [Abstract][Full Text] [Related]
23. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
[TBL] [Abstract][Full Text] [Related]
24. Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice.
Chen H; Gao N; Wu J; Zheng X; Li J; Fan D; An J
Immunol Lett; 2014 Nov; 162(1 Pt A):140-8. PubMed ID: 25128840
[TBL] [Abstract][Full Text] [Related]
25. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
26. Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.
Widman DG; Frolov I; Mason PW
Adv Virus Res; 2008; 72():77-126. PubMed ID: 19081489
[TBL] [Abstract][Full Text] [Related]
27. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.
Heiss BL; Maximova OA; Pletnev AG
J Virol; 2011 Feb; 85(4):1464-72. PubMed ID: 21123372
[TBL] [Abstract][Full Text] [Related]
28. [Flaviviruses].
Ishikawa T; Konishi E
Uirusu; 2011 Dec; 61(2):221-38. PubMed ID: 22916569
[TBL] [Abstract][Full Text] [Related]
29. One antibody to treat them all.
Biering SB
Science; 2022 Feb; 375(6583):803. PubMed ID: 35201864
[TBL] [Abstract][Full Text] [Related]
30. Epitope mapping of flavivirus glycoproteins.
Heinz FX
Adv Virus Res; 1986; 31():103-68. PubMed ID: 2428213
[No Abstract] [Full Text] [Related]
31. Recent advances in flavivirus antiviral drug discovery and vaccine development.
Ray D; Shi PY
Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):45-55. PubMed ID: 18221133
[TBL] [Abstract][Full Text] [Related]
32. Advances in flavivirus vaccine development.
Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
[TBL] [Abstract][Full Text] [Related]
33. Membrane and envelope virus proteins co-expressed as lysosome associated membrane protein (LAMP) fused antigens: a potential tool to develop DNA vaccines against flaviviruses.
Dhalia R; Maciel M; Cruz FS; Viana IF; Palma ML; August T; Marques ET
An Acad Bras Cienc; 2009 Dec; 81(4):663-9. PubMed ID: 19893892
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Apoptosis during Flavivirus Infection.
Okamoto T; Suzuki T; Kusakabe S; Tokunaga M; Hirano J; Miyata Y; Matsuura Y
Viruses; 2017 Aug; 9(9):. PubMed ID: 28846635
[TBL] [Abstract][Full Text] [Related]
35. Mimicking live flavivirus immunization with a noninfectious RNA vaccine.
Kofler RM; Aberle JH; Aberle SW; Allison SL; Heinz FX; Mandl CW
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1951-6. PubMed ID: 14769933
[TBL] [Abstract][Full Text] [Related]
36. Detection of specific immunoglobulin M antibody to different flaviviruses by use of enzyme-labeled antigens.
Schmitz H; Emmerich P
J Clin Microbiol; 1984 May; 19(5):664-7. PubMed ID: 6330165
[TBL] [Abstract][Full Text] [Related]
37. Are tree squirrels involved in the circulation of flaviviruses in Italy?
Romeo C; Lecollinet S; Caballero J; Isla J; Luzzago C; Ferrari N; García-Bocanegra I
Transbound Emerg Dis; 2018 Oct; 65(5):1372-1376. PubMed ID: 29635877
[TBL] [Abstract][Full Text] [Related]
38. Antiviral macrophage responses in flavivirus encephalitis.
Ashhurst TM; Vreden Cv; Munoz-Erazo L; Niewold P; Watabe K; Terry RL; Deffrasnes C; Getts DR; Cole King NJ
Indian J Med Res; 2013 Nov; 138(5):632-47. PubMed ID: 24434318
[TBL] [Abstract][Full Text] [Related]
39. Flavivirus DNA vaccines: current status and potential.
Chang GJ; Davis BS; Hunt AR; Holmes DA; Kuno G
Ann N Y Acad Sci; 2001 Dec; 951():272-85. PubMed ID: 11797784
[TBL] [Abstract][Full Text] [Related]
40. Nucleic acid-based inhibition of flavivirus infections.
Stein DA; Shi PY
Front Biosci; 2008 Jan; 13():1385-95. PubMed ID: 17981637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
